REGISTERED
on 23 Jul 2019
Last Applicant/ Owned by
51 Technology Drive
Anderson
SC
29625
Serial Number
87919375 filed on 14th May 2018
Registration Number
5810344 registered on 23rd Jul 2019
Correspondent Address
Mary Anthony Merchant
Filing Basis
1. filed as use application
2. use application currently
Disclaimer
NO DATA
GLYCOPRENE
Medical apparatus for use in surgery, namely, absorbable surgical mesh comprised primarily of synthetic materials; Suture materials in the nature of absorbable monofilament for medical uses, namely, for use in sutures and as a fiducial marker; suture materials in the nature of multifilament for use in sutures; injection molded articles, namely, surgical staples and surgical fasteners
Classification Information
Class [010]
Medical Instrument Products
Medical apparatus for use in surgery, namely, absorbable surgical mesh comprised primarily of synthetic materials; Suture materials in the nature of absorbable monofilament for medical uses, namely, for use in sutures and as a fiducial marker; suture materials in the nature of multifilament for use in sutures; injection molded articles, namely, surgical staples and surgical fasteners
First Use Date in General
01st Apr 2009
First Use Date in Commerce
01st Apr 2009
Mark Details
Serial Number
No 87919375
Mark Type
No Service/Collective Mark
Attorney Docket Number
No
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 23rd Jul 2024 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| 23rd Jul 2019 | REGISTERED-PRINCIPAL REGISTER |
| 08th Jul 2019 | ASSIGNED TO EXAMINER |
| 07th May 2019 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 07th May 2019 | PUBLISHED FOR OPPOSITION |
| 17th Apr 2019 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 29th Mar 2019 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| 29th Mar 2019 | ASSIGNED TO LIE |
| 11th Mar 2019 | EXAMINERS AMENDMENT -WRITTEN |
| 11th Mar 2019 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |